Tara Bancroft
Stock Analyst at TD Cowen
(4.86)
# 356
Out of 4,512 analysts
270
Total ratings
54.8%
Success rate
31.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Maintained: Buy | $35 | $39.19 | -10.69% | 22 | Jun 16, 2026 | |
| KLRS Kalaris Therapeutics | Initiated Coverage: Buy | n/a | $4.55 | - | 1 | Jun 15, 2026 | |
| IRON Disc Medicine | Initiated Coverage: Buy | n/a | $75.14 | - | 13 | Jun 3, 2026 | |
| CELC Celcuity | Maintained: Buy | n/a | $111.05 | - | 13 | May 14, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | n/a | $26.03 | - | 12 | May 14, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | n/a | $2.99 | - | 13 | May 13, 2026 | |
| XNCR Xencor | Maintained: Buy | n/a | $14.95 | - | 12 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Maintained: Hold | n/a | $3.64 | - | 2 | May 10, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $85 → $105 | $102.37 | +2.57% | 19 | May 7, 2026 | |
| WHWK Whitehawk Therapeutics | Maintained: Hold | n/a | $3.81 | - | 12 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.38 | +117.39% | 19 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $13.73 | +45.67% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $54.89 | -8.91% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $56.21 | +33.43% | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $27.28 | - | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $9.70 | +106.19% | 23 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $131.27 | -23.82% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.21 | - | 12 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $41.64 | - | 3 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.93 | - | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.29 | - | 14 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20.00 | $15.78 | +26.74% | 16 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.31 | n/a | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.02 | n/a | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.31 | n/a | 2 | Jul 26, 2024 |
UroGen Pharma
Jun 16, 2026
Maintained: Buy
Price Target: $35
Current: $39.19
Upside: -10.69%
Kalaris Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.55
Upside: -
Disc Medicine
Jun 3, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $75.14
Upside: -
Celcuity
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $111.05
Upside: -
Sutro Biopharma
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $26.03
Upside: -
Fate Therapeutics
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $2.99
Upside: -
Xencor
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $14.95
Upside: -
Rocket Pharmaceuticals
May 10, 2026
Maintained: Hold
Price Target: n/a
Current: $3.64
Upside: -
Lantheus Holdings
May 7, 2026
Maintained: Buy
Price Target: $85 → $105
Current: $102.37
Upside: +2.57%
Whitehawk Therapeutics
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $3.81
Upside: -
May 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.38
Upside: +117.39%
May 6, 2026
Maintained: Buy
Price Target: $20
Current: $13.73
Upside: +45.67%
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $54.89
Upside: -8.91%
May 6, 2026
Maintained: Buy
Price Target: $75
Current: $56.21
Upside: +33.43%
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $27.28
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $20
Current: $9.70
Upside: +106.19%
May 5, 2026
Maintained: Buy
Price Target: $100
Current: $131.27
Upside: -23.82%
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $4.21
Upside: -
Apr 1, 2026
Maintained: Buy
Price Target: n/a
Current: $41.64
Upside: -
Mar 11, 2026
Maintained: Buy
Price Target: n/a
Current: $0.93
Upside: -
Mar 10, 2026
Rated: Hold
Price Target: n/a
Current: $4.29
Upside: -
Feb 19, 2026
Maintained: Buy
Price Target: $20.00
Current: $15.78
Upside: +26.74%
Mar 14, 2025
Rated: Hold
Price Target: n/a
Current: $1.31
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: n/a
Current: $6.02
Upside: n/a
Jul 26, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.31
Upside: n/a